Evaluating Safety and Efficacy of Mesenchymal Stem Cells From Umbilical Cord
Not Applicable
- Conditions
- Umbilical Cord BleedingKnee Osteoarthritis
- Interventions
- Drug: mesenchymal stem cells from umbilical cord
- First Posted Date
- 2017-11-30
- Last Posted Date
- 2017-11-30
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT03358654
Investigation on the Surgical Treatment Effect of Periprosthetic Femur Fracture After Hip Arthroplasty
- Conditions
- Periprosthetic Fractures
- Interventions
- Procedure: surgically treated periprosthetic femur fracture
- First Posted Date
- 2017-11-30
- Last Posted Date
- 2017-11-30
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 155
- Registration Number
- NCT03358186
Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osteosarcoma
Not yet recruiting
- Conditions
- Osteosarcoma
- Interventions
- Other: Molecular Profiling & In Vivo drug testing in PDX
- First Posted Date
- 2017-11-30
- Last Posted Date
- 2017-11-30
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT03358628
The Difference of Angle of Femoral Component Rotation in TKA With Gap Balance and Measured Resection Technique
Not Applicable
- Conditions
- Osteoarthritis, Knee
- Interventions
- Procedure: the measured resection type of total knee arthroplastyProcedure: the gap balance type of total knee arthroplasty
- First Posted Date
- 2017-11-30
- Last Posted Date
- 2017-11-30
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT03358381
Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
Phase 2
Withdrawn
- Conditions
- Progression-free SurvivalOverall SurvivalToxicity
- Interventions
- First Posted Date
- 2017-11-14
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Peking University People's Hospital
- Registration Number
- NCT03342300
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
Epigenetic Biomarker for Osteosarcoma
- Conditions
- Histologic Response (Tumor Necrosis Rate)Progression-free Survival, PFSOverall Survival, OSObjective Response Rate for Neoadjuvant Chemotherapy, ORR
- First Posted Date
- 2017-11-08
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT03336554
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
C-CAR011 Treatment in Subjects With ALL After HSCT
Not Applicable
- Conditions
- Acute Lymphoblastic Leukemia(ALL)
- Interventions
- Biological: C-CAR011
- First Posted Date
- 2017-10-31
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03327285
- Locations
- 🇨🇳
Peking University Institute of Hematology, Beijing, Beijing, China
Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing
Completed
- Conditions
- Lung NeoplasmCarcinomaNon-small-cell Lung Cancer
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2019-01-09
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT03320044
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
- First Posted Date
- 2017-10-09
- Last Posted Date
- 2021-01-20
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 168
- Registration Number
- NCT03304288
- Locations
- 🇨🇳
Beijing Tongren Hospital, Beijing, Beijing, China
🇨🇳Navy General Hospital, Beijing, Beijing, China
🇨🇳Beijing Hospital, Beijing, Beijing, China
Multiplex Analysis of Circulating Tumor DNA
- Conditions
- Non-small-cell Lung CancerLung NeoplasmCarcinoma
- First Posted Date
- 2017-10-04
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT03301961
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath